Indeed, DDX11-AS1, a long non-coding RNA found to be upregulated in liver cancer patients, affects the interaction between p53 and PARP1, resulting in decreased CDKN1A/p21 expression at both the transcriptional and protein levels. The gene discussed is CDKN1A; the disease is liver cancer.